KHB(002022)

Search documents
科华生物(002022) - 关于产品获得医疗器械注册证的公告
2025-09-18 07:45
| 证券代码:002022 | 证券简称:科华生物 | 公告编号:2025-059 | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | | 上海科华生物工程股份有限公司 关于产品获得医疗器械注册证的公告 近日,上海科华生物工程股份有限公司(以下简称"公司")收到上海市药 品监督管理局颁发的医疗器械注册证(体外诊断试剂)。具体情况如下: 2025年9月19日 | 序号 | 产品名称 | 注册证编号 | 注册证有效期 | 适用范围/预期用途 | | --- | --- | --- | --- | --- | | 1 | 铁蛋白 测定试剂盒 (胶乳免疫 比浊法) | 20252400408 | 2025年09月17日 至 2030年09月16日 | 本试剂盒供医疗机构用于 体外定量测定人血清、血 浆样本中铁蛋白(FER)的 含量。临床上主要用于铁 代谢的相关疾病,如血色 素沉着症和缺铁性贫血的 | | | | 沪械注准 | | | | | | | | 辅助诊断。 | 以上新产品医疗器械注册证的取得,丰富了公司产品线,将对公司业务发展 具有正面影响。公司目前尚无法预测上 ...
科华生物(002022) - 关于“科华转债”回售结果的公告
2025-09-17 08:47
| 证券代码:002022 | 证券简称:科华生物 | | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | 公告编号:2025-058 | 上海科华生物工程股份有限公司 关于"科华转债"回售结果的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、债券代码:128124,债券简称:科华转债 2、回售价格:100.241 元人民币/张(含息、税) 3、回售申报期:2025 年 9 月 10 日至 2025 年 9 月 16 日 4、回售有效申报张数:70 张 6、发行人资金到账日:2025 年 9 月 19 日 7、回售款划拨日:2025 年 9 月 22 日 8、投资者回售款到账日:2025 年 9 月 23 日 一、本次可转换公司债券回售的公告情况 上海科华生物工程股份有限公司(以下简称"公司")根据《深圳证券交易 所股票上市规则》、《深圳证券交易所上市公司自律监管指引第 15 号——可转 换公司债券》等法律法规的有关规定以及《上海科华生物工程股份有限公司公开 发行可转换公司债券募集说明书》的 ...
上海科华生物工程股份有限公司 关于“科华转债”回售的第六次提示性公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-16 02:19
Core Viewpoint - The company announces the conditional redemption of its convertible bonds, "Kehua Convertible Bonds," with specific terms and conditions for bondholders to exercise their redemption rights [1][2][3]. Redemption Overview - Redemption Price: 100.241 RMB per bond (including interest and tax) [1][6]. - Trigger Date for Redemption Conditions: September 5, 2025 [1]. - Redemption Period: September 10 to September 16, 2025 [2][9]. - Payment Dates: Funds will be credited to the company on September 19, 2025, with redemption payments to investors on September 23, 2025 [2][9]. Redemption Conditions - The redemption clause is activated if the company's stock price remains below 70% of the conversion price (14.45 RMB) for 30 consecutive trading days [1][12]. - Bondholders can redeem all or part of their unconverted bonds, and the redemption is not mandatory [7][12]. Interest Calculation - The interest for the current period is calculated as follows: IA = B × i × t / 365, where B is the total face value of the bonds, i is the annual coupon rate (2.00%), and t is the number of days from the last interest payment to the start of the redemption period [4][5]. - The calculated interest per bond is 0.241 RMB, leading to a total redemption price of 100.241 RMB per bond [5][6]. Redemption Process - Bondholders must submit their redemption requests through the Shenzhen Stock Exchange trading system during the specified redemption period [9]. - The company will announce the results of the redemption and its impact on the company after the redemption period ends [9]. Suspension and Resumption of Conversion - The conversion of "Kehua Convertible Bonds" will be suspended during the redemption period (September 10 to September 16, 2025) and will resume on September 17, 2025 [11][12].
科华生物(002022) - 关于“科华转债”恢复转股的公告
2025-09-15 09:16
特别提示: | 证券代码:002022 | 证券简称:科华生物 | 公告编号:2025-057 | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | | 上海科华生物工程股份有限公司 关于"科华转债"恢复转股的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 16 日(星期二)止。具体详见公司于 2025 年 9 月 8 日披露的《关于回售期间"科 华转债"暂停转股的公告》(公告编号:2025-049)。 "科华转债"将在本次回售申报期结束的次一交易日,即 2025 年 9 月 17 日(星期三)起恢复转股。敬请公司可转换公司债券持有人注意。 1、债券代码:128124,债券简称:科华转债 特此公告。 2、转股起止时间:2021 年 2 月 3 日至 2026 年 7 月 27 日 上海科华生物工程股份有限公司董事会 3、暂停转股时间:2025 年 9 月 10 日至 2025 年 9 月 16 日 4、恢复转股时间:2025 年 9 月 17 日 经中国证券监督管理委员会"证监许可[2020]970 号"文核 ...
科华生物(002022) - 关于“科华转债”回售的第六次提示性公告
2025-09-15 09:16
上海科华生物工程股份有限公司 关于"科华转债"回售的第六次提示性公告 | 证券代码:002022 | 证券简称:科华生物 | | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | 公告编号:2025-056 | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、回售价格:100.241 元人民币/张(含息、税) 2、回售条件触发日:2025 年 9 月 5 日 3、回售申报期:2025 年 9 月 10 日至 2025 年 9 月 16 日 4、发行人资金到账日:2025 年 9 月 19 日 5、回售款划拨日:2025 年 9 月 22 日 6、投资者回售款到账日:2025 年 9 月 23 日 7、回售申报期内停止转股 8、本次回售不具有强制性 9、在回售款划拨日之前,如已申报回售的可转换公司债券发生司法冻结或 扣划等情形,债券持有人本次回售申报业务失效。 10、风险提示:投资者选择回售等同于以 100.241 元人民币/张(含息、税) 卖出持有的"科华转债"。截至目前,"科华转债"的收盘价格高于 ...
上海科华生物工程股份有限公司关于“科华转债”回售的第五次提示性公告
Shang Hai Zheng Quan Bao· 2025-09-14 19:46
Core Points - The company announced the conditional redemption of its convertible bonds, "Kehua Convertible Bonds," with a redemption price of 100.241 RMB per bond, including interest and tax [1][7] - The redemption condition is triggered if the company's stock price falls below 70% of the conversion price for 30 consecutive trading days, specifically below 14.45 RMB per share [1][4] - The redemption period is set from September 10, 2025, to September 16, 2025, with the funds being transferred to bondholders by September 23, 2025 [2][10] Redemption Terms - The redemption price consists of the bond's face value plus accrued interest, calculated based on a 2.00% annual interest rate for the sixth interest period [5][6] - The accrued interest for the redemption period is calculated to be 0.241 RMB per bond, leading to a total redemption price of 100.241 RMB [6][7] - The company will not withhold income tax for certain investors, while individual investors will have a net redemption amount of 100.193 RMB after tax [7] Redemption Rights - Bondholders have the right to redeem either part or all of their unconverted "Kehua Convertible Bonds," and the redemption is not mandatory [8] - The company will publish announcements regarding the redemption conditions, application period, and payment methods in compliance with regulatory requirements [9] Redemption Process - Bondholders must submit their redemption applications through the Shenzhen Stock Exchange trading system during the specified application period [10] - The company will handle the redemption payments through the China Securities Depository and Clearing Corporation [10]
科华生物(002022) - 关于“科华转债”回售的第五次提示性公告
2025-09-14 07:45
| 证券代码:002022 | 证券简称:科华生物 | | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | 公告编号:2025-055 | 上海科华生物工程股份有限公司 关于"科华转债"回售的第五次提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、回售价格:100.241 元人民币/张(含息、税) 2、回售条件触发日:2025 年 9 月 5 日 3、回售申报期:2025 年 9 月 10 日至 2025 年 9 月 16 日 4、发行人资金到账日:2025 年 9 月 19 日 7、回售申报期内停止转股 8、本次回售不具有强制性 9、在回售款划拨日之前,如已申报回售的可转换公司债券发生司法冻结或 扣划等情形,债券持有人本次回售申报业务失效。 10、风险提示:投资者选择回售等同于以 100.241 元人民币/张(含息、税) 卖出持有的"科华转债"。截至目前,"科华转债"的收盘价格高于本次回售价 格,投资者选择回售可能会带来损失,敬请广大投资者注意风险。 上海科华生物工程股份有限公司(以下 ...
上海科华生物工程股份有限公司关于“科华转债”回售的第四次提示性公告
Shang Hai Zheng Quan Bao· 2025-09-11 19:14
Core Viewpoint - The announcement details the conditional redemption of "Kehua Convertible Bonds" by Shanghai Kehua Bioengineering Co., Ltd., triggered by specific stock price conditions and outlines the redemption process and terms [1][2][3]. Redemption Conditions - The redemption price is set at 100.241 RMB per bond (including interest and tax) [1][6]. - The triggering date for the redemption conditions is September 5, 2025, when the stock price falls below 70% of the conversion price for 30 consecutive trading days [1][2]. - The redemption is not mandatory, allowing bondholders to choose whether to redeem their bonds [1][7]. Redemption Process - The redemption application period is from September 10 to September 16, 2025 [2][9]. - The funds will be credited to the issuer on September 19, 2025, with the redemption payment date set for September 22, 2025, and investors will receive their funds by September 23, 2025 [2][9]. Interest Calculation - The interest for the redemption is calculated using the formula: IA = B × i × t / 365, where the interest rate (i) is 2.00% for the sixth interest year [4][5]. - The calculated interest per bond is 0.241 RMB, leading to a total redemption price of 100.241 RMB per bond [5][6]. Trading and Conversion Restrictions - During the redemption application period, "Kehua Convertible Bonds" will continue to trade but will not allow conversion into shares [9]. - If bondholders submit multiple requests (trading, conversion, redemption) on the same day, they will be processed in a specific order: trading, redemption, conversion, and transfer [9].
科华生物(002022) - 关于“科华转债”回售的第四次提示性公告
2025-09-11 08:17
特别提示: | 证券代码:002022 | 证券简称:科华生物 | | | --- | --- | --- | | 债券代码:128124 | 债券简称:科华转债 | 公告编号:2025-054 | 上海科华生物工程股份有限公司 关于"科华转债"回售的第四次提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 8、本次回售不具有强制性 1、回售价格:100.241 元人民币/张(含息、税) 2、回售条件触发日:2025 年 9 月 5 日 3、回售申报期:2025 年 9 月 10 日至 2025 年 9 月 16 日 4、发行人资金到账日:2025 年 9 月 19 日 5、回售款划拨日:2025 年 9 月 22 日 6、投资者回售款到账日:2025 年 9 月 23 日 7、回售申报期内停止转股 9、在回售款划拨日之前,如已申报回售的可转换公司债券发生司法冻结或 扣划等情形,债券持有人本次回售申报业务失效。 10、风险提示:投资者选择回售等同于以 100.241 元人民币/张(含息、税) 卖出持有的"科华转债"。截至目前,"科华转债"的收盘价格高于 ...
上海科华生物工程股份有限公司关于“科华转债”回售的第三次提示性公告
Shang Hai Zheng Quan Bao· 2025-09-10 20:07
Core Viewpoint - The announcement details the conditional redemption of "Kehua Convertible Bonds" by Shanghai Kehua Bioengineering Co., Ltd, triggered by specific stock price conditions and outlines the redemption process and terms [1][2][6]. Redemption Conditions - The redemption price is set at 100.241 RMB per bond (including interest and tax) [1][6]. - The triggering date for the redemption conditions is September 5, 2025, when the stock price must be below 70% of the conversion price for 30 consecutive trading days [1][2][4]. Redemption Process - The redemption application period is from September 10 to September 16, 2025 [2][8]. - The funds will be credited to the issuer's account on September 19, 2025, with the redemption payment date set for September 22, 2025, and investors will receive the funds by September 23, 2025 [2][8]. Interest Calculation - The interest for the redemption is calculated based on a rate of 2.00% for the sixth interest period, resulting in an accrued interest of 0.241 RMB per bond [4][5][6]. Tax Implications - Individual investors will have a net redemption amount of 100.193 RMB per bond after a 20% tax deduction, while qualified foreign institutional investors (QFII and RQFII) are exempt from tax [6]. Trading and Conversion Restrictions - During the redemption application period, "Kehua Convertible Bonds" will continue to trade but will not allow conversion into shares [8].